Elko Medical Weight Loss Treatment Semaglutide Telehealth in Elko, NV Semaglutide (Wegovy/Ozempic) is an GLP-1 (glucagon-like peptide), FDA approved for weekly use to treat obesity
For injectable semaglutide, diarrhea does not usually affect how much medication your body absorbs
However, this effect varies individually and has not been definitively established in clinical trials, so patients should monitor their own symptom patterns and discuss timing adjustments with their healthcare provider
Some patients describe a sensation of pressure or heaviness in the epigastric region (upper central abdomen)
If side effects worsen after one month, consult your provider about dose adjustments
These check-ins are necessary to track weight loss progress and make adjustments when needed to ensure patients are on track and progressing well